Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Biophys Chem ; 220: 34-41, 2017 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-27863716

RESUMO

The 140-residue natively disordered protein α-synuclein (aSN) is a central component in the development of a family of neurodegenerative diseases termed synucleinopathies. This is attributed to its ability to form cytotoxic aggregates such as oligomers and amyloid fibrils. Consequently there have been intense efforts to avoid aggregation or reroute the aggregation pathway using pharmaceutical agents such as small molecules, chaperones and antibodies. aSN's lack of persistent structure in the monomeric state, as well as the multitude of different oligomeric and even different fibrillar states, makes it difficult to raise antibodies that would be efficacious in neutralizing all conformations of aSN. However, the C-terminal 20-40 residues of aSN are a promising epitope for antibody development. It is primarily disordered in both monomeric and aggregated forms, and an anti-C-terminal antibody will therefore be able to bind all forms. Furthermore, it might not interfere with the folding of aSN into membranes, which could be important for its physiological role. Here we report a screen of a series of monoclonal antibodies, which all target the C-terminal of aSN. According to dot blot analyses, different antibodies bound different forms of aSN with different preferences and showed reduced binding to monomeric compared to aggregated (oligomeric and fibrillary) aSN. Consequently they have different effects on aSN's ability to fibrillate and permeabilize membranes. Generally, the antibodies with strongest binding to aggregated aSN in dot blot, also inhibited fibrillation and membrane permeabilization the most, and promoted formation of amorphous aggregates surrounded by small and thin fibers. This suggests that the development of antibodies that targets the C-terminus, exposed in the aggregated forms of aSN, may be beneficial for improved immunotherapy against PD.


Assuntos
Amiloide/efeitos dos fármacos , Anticorpos Monoclonais/farmacologia , Agregação Patológica de Proteínas/prevenção & controle , alfa-Sinucleína/imunologia , Animais , Permeabilidade da Membrana Celular/efeitos dos fármacos , Humanos , Camundongos , Doença de Parkinson/tratamento farmacológico , Agregados Proteicos/efeitos dos fármacos , Agregação Patológica de Proteínas/tratamento farmacológico
2.
Mech Ageing Dev ; 135: 1-14, 2014 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-24406253

RESUMO

Cockayne Syndrome is a segmental premature aging syndrome, which can be caused by loss of function of the CSB protein. CSB is essential for genome maintenance and has numerous interaction partners with established roles in different DNA repair pathways including transcription coupled nucleotide excision repair and base excision repair. Here, we describe a new interaction partner for CSB, the DNA glycosylase NEIL2. Using both cell extracts and recombinant proteins, CSB and NEIL2 were found to physically interact independently of DNA. We further found that CSB is able to stimulate NEIL2 glycosylase activity on a 5-hydroxyl uracil lesion in a DNA bubble structure substrate in vitro. A novel 4,6-diamino-5-formamidopyrimidine (FapyA) specific incision activity of NEIL2 was also stimulated by CSB. To further elucidate the biological role of the interaction, immunofluorescence studies were performed, showing an increase in cytoplasmic CSB and NEIL2 co-localization after oxidative stress. Additionally, stalling of the progression of the transcription bubble with α-amanitin resulted in increased co-localization of CSB and NEIL2. Finally, CSB knockdown resulted in reduced incision of 8-hydroxyguanine in a DNA bubble structure using whole cell extracts. Taken together, our data supports a biological role for CSB and NEIL2 in transcription associated base excision repair.


Assuntos
DNA Glicosilases/metabolismo , DNA Helicases/metabolismo , Enzimas Reparadoras do DNA/metabolismo , DNA Liase (Sítios Apurínicos ou Apirimidínicos)/metabolismo , Regulação Enzimológica da Expressão Gênica , Citoplasma/metabolismo , DNA/química , Reparo do DNA , Escherichia coli/metabolismo , Guanina/análogos & derivados , Guanina/química , Células HeLa , Humanos , Microscopia de Fluorescência , Estresse Oxidativo , Proteínas de Ligação a Poli-ADP-Ribose , Proteínas Recombinantes/metabolismo , Transcrição Gênica , Vitamina K 3/química
3.
FEBS Lett ; 588(3): 497-502, 2014 Jan 31.
Artigo em Inglês | MEDLINE | ID: mdl-24374342

RESUMO

The intrinsically disordered protein α-synuclein (αSN) is linked to Parkinson's Disease and forms both oligomeric species and amyloid fibrils. The N-terminal part of monomeric αSN interacts strongly with membranes and αSN cytotoxicity has been attributed to oligomers' ability to interact with and perturb membranes. We show that membrane folding of monomeric wt αSN and N-terminally truncated variants correlates with membrane permeabilization. Further, the first 11 N-terminal residues are crucial for monomers' and oligomers' interactions with and permeabilization of membranes. We attribute oligomer permeabilization both to cooperative electrostatic interactions through the N-terminus and interactions mediated by hydrophobic regions in the oligomer.


Assuntos
Amiloide/química , Doença de Parkinson/metabolismo , alfa-Sinucleína/química , Amiloide/metabolismo , Amiloide/ultraestrutura , Permeabilidade da Membrana Celular/genética , Humanos , Interações Hidrofóbicas e Hidrofílicas , Membranas/química , Membranas/ultraestrutura , Doença de Parkinson/etiologia , Doença de Parkinson/patologia , Multimerização Proteica , Estrutura Quaternária de Proteína , Eletricidade Estática , alfa-Sinucleína/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA